Asylia Diagnostics Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 11

Asylia Diagnostics General Information

Description

Developer of molecular diagnostics tests designed to provide safer immunotherapy for cancer patients. The company's approach is based on a transformative concept that leverages molecular and clinical RWE data and machine learning/AI, allowing de-risk upfront theranostic development, identifying non-responders to SoC, dissecting patient strata, and finding relevant biomarkers and novel targets to offer precision medicine systems for patients, enabling cancer patients to avail better and faster diagnosis.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • JLABS at BE, Janssen Pharmaceutica NV Beerse Site 1
  • Turnhoutseweg 30
  • 2340 Beerse
  • Belgium
Primary Industry
Discovery Tools (Healthcare)
Corporate Office
  • JLABS at BE, Janssen Pharmaceutica NV Beerse Site 1
  • Turnhoutseweg 30
  • 2340 Beerse
  • Belgium

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Asylia Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Accelerator/Incubator Completed Clinical Trials - Phase 1
5. Later Stage VC 18-Feb-2025 Completed Clinical Trials - Phase 1
4. Seed Round 25-Oct-2021 Completed Pre-Clinical Trials
3. Accelerator/Incubator 02-Jun-2020 Completed Pre-Clinical Trials
2. Accelerator/Incubator 16-Sep-2019 $55.3K $55.3K Completed Pre-Clinical Trials
1. Accelerator/Incubator 01-Jan-2019 Completed Startup
To view Asylia Diagnostics’s complete valuation and funding history, request access »

Asylia Diagnostics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary Shares
To view Asylia Diagnostics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Asylia Diagnostics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of molecular diagnostics tests designed to provide safer immunotherapy for cancer patients. The company's appr
Discovery Tools (Healthcare)
Beerse, Belgium
8 As of 2025

Boston, MA
 

Menlo Park, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Asylia Diagnostics Competitors (2)

One of Asylia Diagnostics’s 2 competitors is Foundation Medicine, a Formerly VC-backed company based in Boston, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Foundation Medicine Formerly VC-backed Boston, MA
GRAIL Formerly VC-backed Menlo Park, CA
You’re viewing 2 of 2 competitors. Get the full list »

Asylia Diagnostics Patents

Asylia Diagnostics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2022315526-A1 Biomarkers for therapy response after immunotherapy Pending 22-Jul-2021
EP-4373974-A1 Biomarkers for therapy response after immunotherapy Active 22-Jul-2021
EP-4373974-B1 Biomarkers for therapy response after immunotherapy Active 22-Jul-2021
EP-4373974-C0 Biomarkers for therapy response after immunotherapy Active 22-Jul-2021
ES-3073634-T3 Biomarkers for therapy response after immunotherapy Active 22-Jul-2021 C12Q1/6886
To view Asylia Diagnostics’s complete patent history, request access »

Asylia Diagnostics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Asylia Diagnostics Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
AstraZeneca Corporation Minority
Az Alma Corporation Minority
Becton, Dickinson and Company Corporation Minority
Biocartis Group Corporation Minority
Tempus AI Corporation Minority
You’re viewing 5 of 11 investors. Get the full list »

Asylia Diagnostics FAQs

  • When was Asylia Diagnostics founded?

    Asylia Diagnostics was founded in 2019.

  • Where is Asylia Diagnostics headquartered?

    Asylia Diagnostics is headquartered in Beerse, Belgium.

  • What is the size of Asylia Diagnostics?

    Asylia Diagnostics has 8 total employees.

  • What industry is Asylia Diagnostics in?

    Asylia Diagnostics’s primary industry is Discovery Tools (Healthcare).

  • Is Asylia Diagnostics a private or public company?

    Asylia Diagnostics is a Private company.

  • What is Asylia Diagnostics’s current revenue?

    The current revenue for Asylia Diagnostics is .

  • How much funding has Asylia Diagnostics raised over time?

    Asylia Diagnostics has raised $1.66M.

  • Who are Asylia Diagnostics’s investors?

    AstraZeneca, Az Alma, Becton, Dickinson and Company, Biocartis Group, and Tempus AI are 5 of 11 investors who have invested in Asylia Diagnostics.

  • Who are Asylia Diagnostics’s competitors?

    Foundation Medicine and GRAIL are competitors of Asylia Diagnostics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process